- Price is above Fair Value, showing premium demand versus the model.
- Latest weekly return ranks in the strongest part of its sector group.
KMK
LSE
Week ended 07 Aug 2026
Weekly Investor Report
Kromek Group plc · Technology · Scientific & Technical Instruments
Latest close
0.09 GBP
15.5%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -12.1% below the Trend Line and sits at 46.4% of its 52-week range. The latest completed week returned 15.5%, after a -0.3% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 53/100.
Setup score
30
out of 100
Latest Close
0.09 GBP
7 Aug 2026
1W Return
15.5%
latest completed week
4W Return
-0.3%
short-term follow-through
12W Return
-9.0%
quarterly tape
Trend Breadth
65.4%
34 of 52 weeks active
Volume Ratio
1.4x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Activity pressure is negative, which weakens the current setup.
- Next-week expectancy is negative at 40.85% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
15.5%
Latest completed week; four-week move -0.3%.
Indicator stack
36/35
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 40.85%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
53/100
11 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -12.1% below the Trend Line and sits at 46.4% of its 52-week range. The latest completed week returned 15.5%, after a -0.3% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.4x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0912-week average 0.31
12-week confirmation
Trend active2/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership4/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.09Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -0.3% over four weeks, -9.0% over 12 weeks, and 71.0% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year34
Trend breadth65.4%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.91Latest activity-pressure read.
Pressure change18.1%Four-week change in activity pressure.
Leadership-6.27Latest relative-leadership reading.
RS change-589.5%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 09 Aug 2026
Financial statements through 31 Oct 2025
Field coverage 39%
Model confidence 28%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength93/100Blend of value, momentum, and quality. Underlying universe rank 8; rank 1 is best.
Value78/100Relative valuation strength. Underlying universe rank 23; rank 1 is best.
Quality80/100Profitability and accounting quality. Underlying universe rank 21; rank 1 is best.
Momentum80/100Medium-term price momentum. Underlying universe rank 21; rank 1 is best.
Growth80/100Revenue and earnings growth. Underlying universe rank 21; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- - Price divided by trailing earnings.
- Price / sales
- - Market value relative to trailing revenue.
- EV / EBITDA
- - Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- - Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- - Gross profit retained from each unit of revenue.
- Operating margin
- - Operating profit retained from revenue.
- Free-cash-flow margin
- - Free cash flow generated from revenue.
- Return on invested capital
- - Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- - Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 0/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 0.0% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- - Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment53/100
Weighted news tone is neutral across 11 relevant articles.
2 positive · 9 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-34.2%Distance below the 52-week high.
13-week volatility8.6%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher11 of 2613 weeks finished lower.
Best week+15.5%Week of 7 Aug.
Worst week-11.6%Week of 5 Jun.
Latest week+15.5%Week of 7 Aug.
Shape of recent returns
Strong gains6
Modest gains5
Flat weeks2
Modest losses2
Sharp losses11
Recent vol8.6%13-week weekly-return volatility.
Base vol8.6%52-week weekly-return volatility.
Up/down split23/24Count of positive and negative weeks in the 52-week window.
Average skew9.0% / -5.6%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorGB Technology
4-week rank59 / 100
Group average2.8%
Trend breadth37.0%
Trend37.0%active weekly trend signals
MD58.0%positive activity pressure
RS34.0%positive relative leadership
Four-week leaders
IndustryGB Scientific & Technical Instruments
4-week rank5 / 11
Group average1.4%
Trend breadth45.5%
Trend45.5%active weekly trend signals
MD36.4%positive activity pressure
RS45.5%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape28/100
Trend, activity pressure, participation, and risk combine to a 28/100 tape read.
Indicator analysis20/100Latest 12-week confirmation: trend 2/12, activity pressure 0/12, relative leadership 4/12.
Activity pressure 0.09; No reversal markers Next-Week ExpectancyNegative 40.85%Next-week expectancy is negative with a 40.85% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors82/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 48 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment53/100Weighted news tone is neutral across 11 relevant articles.
Kromek Group Plc Revenue Breakdown – LSE:KMK Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 0.09 GBP | 15.5% | 0.10 GBP | 0.07 GBP | -0.91 | -6.27 | 6.1M | Off |
| 31 Jul 2026 | 0.07 GBP | -7.5% | 0.10 GBP | 0.07 GBP | -1.04 | -18.19 | 6.1M | Off |
| 24 Jul 2026 | 0.08 GBP | -1.2% | 0.10 GBP | 0.07 GBP | -1.01 | -10.25 | 4.4M | Off |
| 17 Jul 2026 | 0.08 GBP | -5.6% | 0.10 GBP | 0.07 GBP | -1.06 | -7.70 | 3.2M | Off |
| 10 Jul 2026 | 0.09 GBP | -3.6% | 0.10 GBP | 0.07 GBP | -1.12 | -0.91 | 3.7M | Off |
| 3 Jul 2026 | 0.09 GBP | 13.5% | 0.10 GBP | 0.07 GBP | -1.24 | 1.50 | 1.8M | Off |
| 26 Jun 2026 | 0.08 GBP | -9.4% | 0.10 GBP | 0.07 GBP | -1.31 | -8.69 | 1.0M | Off |
| 19 Jun 2026 | 0.09 GBP | 10.2% | 0.10 GBP | 0.07 GBP | -1.29 | 2.34 | 308.9K | Off |
| 12 Jun 2026 | 0.08 GBP | -6.5% | 0.10 GBP | 0.07 GBP | -1.17 | -7.78 | 919.8K | Off |
| 5 Jun 2026 | 0.08 GBP | -11.6% | 0.10 GBP | 0.07 GBP | -1.07 | -0.25 | 9.0M | Off |
| 29 May 2026 | 0.10 GBP | 0.0% | 0.10 GBP | 0.07 GBP | -0.98 | 12.68 | 2.6M | On |
| 22 May 2026 | 0.10 GBP | 1.1% | 0.10 GBP | 0.06 GBP | -0.83 | 12.66 | 10.5M | On |
| 15 May 2026 | 0.09 GBP | -8.3% | 0.09 GBP | 0.06 GBP | -0.81 | 15.09 | 7.1M | On |
| 8 May 2026 | 0.10 GBP | -4.7% | 0.09 GBP | 0.06 GBP | -0.71 | 25.76 | 6.8M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.